Navkar Corporation Limited stock analysis

OPPORTUNITIES • Gati Shakti GCT expansion: Following the Somathane GCT LOA, Navkar is well-positioned to participate in future GCT bids at other strategic locations, building an asset-light national rail terminal network. • Morbi ICD ramp-up: With domestic cargo volumes growing at 35–45 percent year-on-year and warehousing capacity scalable to 8 lakh square feet, the Morbi ICD has significant operating leverage poten

While many DPD containers still require CFS facilities for interim storage and customs processing, the trend is one that Navkar monitors closely and partially addresses through its diversified ICD and rail operations. • Competitor capacity expansion: Increased capacity by competing CFS, ICD, and rail operators — and the development of new terminals — creates pricing pressure and potential market share competition. •

As the business grew, Ajivali CFS II was established to strengthen capacity and broaden service capabilities. The facility secured key regulatory approvals, including public bonded warehouse status and hazardous cargo handling permissions, enabling Navkar to cater to a wider spectrum of importer and exporter requirements across diverse industries. Today, the Ajivali facilities continue to play an important role withi

All periodical compliance filings, inter alia, shareholding pattern, Corporate Governance Report, Corporate announcements, amongst others are in accordance with the SEBI Listing Regulations filed electronically. Presentations made to institutional investors or to the analysts. The Company has timely intimated to the Exchanges presentations made to institutional investors or to the analysts.